GlobeNewswire
-
Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
05/11/2025 -
Telix to Participate in UBS and Jefferies Global Healthcare Conferences
05/11/2025 -
Palvella Therapeutics Announces New QTORIN™ Product Candidate, QTORIN™ Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DSAP), a Rare, Chronic, and Pre-Cancerous Genetic Skin Disease with No FDA-Approved Therapies
05/11/2025 -
Immuron IMM-529 IND approved by FDA
05/11/2025 -
RadNet Expands Comprehensive Remote Scanning Offering with Acquisition of Alpha RT’s Assets
05/11/2025 -
Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion
05/11/2025 -
Maple acquires Beyond ADHD to expand responsible ADHD and mental health care across Canada
05/11/2025 -
Oculis to Participate in Upcoming November Investor Conferences
05/11/2025 -
Oculis to Participate in Upcoming November Investor Conferences
05/11/2025
Pages